GL1X · GenesisL1 explorer

MolNFT v1 · #106787 · protein

Structure of a ubia homolog from archaeoglobus fulgidus bound to dmapp and MG2+

4TQ4 · Prenyltransferase: “Structure of a ubia homolog from archaeoglobus fulgidus bound to dmapp and MG2+”. X-ray diffraction, 2 ligands (DMA, MG), 14 pockets (best druggability 0.88). MolNFT v1 #106787 on GenesisL1: 3D structure, binding…

PDB
4TQ4
Type
protein
Length
1,155 residues
Chains
4
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Prenyltransferase
UniProt
O28625
Ligands
DMA, MG
Pockets
14 · best druggability 0.88

Structure

x-ray diffraction · 4 distinct chains · 75% helix, 1% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
APrenyltransferaseprotein28875% helix, 1% strandO28625
BPrenyltransferaseprotein28975% helix, 1% strandO28625
CPrenyltransferaseprotein28876% helix, 1% strandO28625
DPrenyltransferaseprotein29075% helix, 1% strandO28625

Ligands and binding sites

  • DMA · Dimethylallyl diphosphate · ligand · 4 copies · chains A, B, C, D
  • MG · Magnesium ion · metal · 8 copies · chains A, B, C, D

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

14 pockets found on a 1 Å grid, 5 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
111680.880.8998MG, DMA
26980.880.9169MG, DMA
311110.860.87101MG, DMA
49350.860.8785MG, DMA
57990.800.8252empty

Interfaces

3 interfaces between chains.

  • A–D · 678 Ų buried · 0 hydrogen bonds · protein-protein
  • A–C · 655 Ų buried · 0 hydrogen bonds · protein-protein
  • B–D · 336 Ų buried · 0 hydrogen bonds · protein-protein

Compared structures

  • 4TQ4 · Structure of a UbiA homolog from Archaeoglobus fulgidus bound to DMAPP and Mg2+ · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.